AGIO Earnings

Quarterly EPS
$-1.69
Q4 2024
$-1.55
Q1 2025
$-1.93
Q2 2025
$-1.78
Q3 2025
$-1.85
Q4 2025
$-1.69
Q1 2026
$-1.69
Q2 2026
$-1.09
Q3 2026
Latest Revenue55.4M
Latest Net Income-65045000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$1.0955.4M-65045000+330.0%+38.8%
Q2 2026-$1.6944.7M-100703000+259.3%+12.4%
Q1 2026-$1.6920.7M-99111000+137.7%-9.0%
Q4 2025-$1.8520.0M-108039000+86.1%-9.5%
Q3 2025-$1.7812.9M-103433000+43.7%-110.7%
Q2 2025-$1.9312.5M-112020000+44.6%-14.2%
Q1 2025-$1.558.7M-89289000+6.6%-6.9%
Q4 2024-$1.6910.7M-96523000+51.1%+1.7%
Q3 2024$16.659.0M947.9M——
Q2 2024-$1.698.6M-96118000——
Q1 2024-$1.458.2M-81549000——
Q4 2023-$1.727.1M-95940000——
Agios Pharmaceuticals (AGIO) — Earnings